Literature DB >> 18072097

The effect of amiodarone pretreatment on survival of mice with cocaine toxicity.

Christopher R DeWitt1, Nathan Cleveland, Richard C Dart, Kennon Heard.   

Abstract

INTRODUCTION: Cocaine is a common drug of abuse and use has been associated with ventricular dysrhythmias. Published guidelines suggest that amiodarone is the first line antidysrhythmic for ventricular tachycardia and fibrillation. However, the effects amiodarone in the setting of cocaine toxicity are unknown and unstudied. The purpose of this study was to evaluate the safety and efficacy of amiodarone pretreatment in a murine model of acute cocaine toxicity.
METHODS: This was a randomized, blinded, placebo controlled investigation using male CF-1 mice weighing 29-37 g. First, the safety of an intraperitoneal dose of amiodarone (40 mg/kg) was confirmed in 5 mice. Second, based on preliminary investigations, an approximate intraperitoneal LD50 dose of cocaine (110 mg/kg) was identified and used as the cocaine dose in this study. Animals were then randomized to 2 groups. The control group received 0.5 mL of intraperitoneal 0.9% saline 30 minutes before cocaine. The study group received 40 mg/kg of intraperitoneal amiodarone (40 mg/kg) 30 minutes before cocaine. A blinded observer monitored mice for 2 hours after cocaine administration.
RESULTS: No mice in the amiodarone-only group developed any signs of toxicity or died. In the saline + cocaine group 31/32 (96.9%; 95% CI 83.8 to 99.9) mice seized with a median time to seizure of 2.5 minutes, and 23/32 (71.9%; 95% CI 52.3 to 86.3) died with a median time to death of 5.5 minutes. In the amiodarone + cocaine group 31/33 (93.9%; 95% CI 79.0 to 99.3) mice seized with a median time to seizure of 2.0 minutes, and 24/33 (72.7%; 95% CI 54.5 to 86.7) died with a median time to death of 6.0 minutes. All animals that died did so within 9 minutes. The difference in the proportion of animals dying in the amiodarone + cocaine group compared to the saline + cocaine group was 0.008 (-21 to 22%).
CONCLUSIONS: In this study, pretreatment with amiodarone in cocaine poisoned mice resulted in no change in seizure incidenceor mortality. However, definite conclusions about the reason for these findings cannot be drawn from this model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18072097      PMCID: PMC3550010          DOI: 10.1007/bf03160899

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  66 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes.

Authors:  H Honjo; I Kodama; K Kamiya; J Toyama
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

3.  Nifedipine potentiates the toxic effects of cocaine in mice.

Authors:  Twum-Ampofo Ansah; Littleton H Wade; Prapaporn Kopsombut; Dolores C Shockley
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

4.  Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1. Comparison with sodium bicarbonate and quinidine.

Authors:  A P Winecoff; R J Hariman; J J Grawe; Y Wang; J L Bauman
Journal:  Pharmacotherapy       Date:  1994 Nov-Dec       Impact factor: 4.705

5.  Sex and strain differences in response to cocaine.

Authors:  M L Thompson; L Shuster; E Casey; G C Kanel
Journal:  Biochem Pharmacol       Date:  1984-04-15       Impact factor: 5.858

6.  Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis.

Authors:  D Vaidya; G E Morley; F H Samie; J Jalife
Journal:  Circ Res       Date:  1999-07-23       Impact factor: 17.367

Review 7.  Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death.

Authors:  Jerry L Bauman; Robert J DiDomenico
Journal:  J Cardiovasc Pharmacol Ther       Date:  2002-07       Impact factor: 2.457

8.  Tetracaine protects against cocaine lethality in mice.

Authors:  S A Grant; R S Hoffman; L R Goldfrank
Journal:  Ann Emerg Med       Date:  1993-12       Impact factor: 5.721

9.  Cocaethylene is more potent than cocaine in mediating lethality.

Authors:  W L Hearn; S Rose; J Wagner; A Ciarleglio; D C Mash
Journal:  Pharmacol Biochem Behav       Date:  1991-06       Impact factor: 3.533

10.  Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog.

Authors:  E S Platou; H Refsum
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-03
View more
  5 in total

Review 1.  Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

2.  Administration of ziprasidone for 10 days increases cocaine toxicity in mice.

Authors:  K Heard; S Krier; N R Zahniser
Journal:  Hum Exp Toxicol       Date:  2008-06       Impact factor: 2.903

3.  Radiofrequency ablation of drug refractory ventricular tachycardia related to cocaine use: a feasibility, safety, and efficacy study.

Authors:  Dhanunjaya Lakkireddy; Arun Kanmanthareddy; Mazda Biria; Yeruva Madhu Reddy; Jayasree Pillarisetti; Srijoy Mahapatra; Loren Berenbom; Larry Chinitz; Donita Atkins; Sudharani Bommana; Roderick Tung; Luigi DI Biase; Kalyanam Shivkumar; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-30

4.  Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.

Authors:  Ejaaz A Kalimullah; Sean M Bryant
Journal:  J Med Toxicol       Date:  2008-12

Review 5.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.